Relmada Therapeutics ( ($RLMD) ) has shared an announcement. On September 17, 2025, Relmada Therapeutics updated its corporate presentation, ...

Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profileKT-621 ...

Apple executives stick to one big idea per slide to make product messages stick. Here's how to embrace this fundamental presentation rule.

Imperative Care, Inc. announces positive results from the SYMPHONY-PE Trial evaluating Symphony® Thrombectomy System in the ...

Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...

In the wake of several significant departures from its design team, Apple underscored its dedication to design during its ...

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of ...

Protagonist Therapeutics (PTGX) announced new data from the Phase 3 ICONIC-ADVANCE 1 and 2 studies which assessed the superiority of icotrokinra, ...

Craving a reliable ribeye or a locally-loved specialty? These Virginia steakhouses deliver familiar favorites and ...

LightPath Technologies, Inc. stock soared 120% with BlackDiamond tech, key acquisitions, and new markets. Click here to read ...

Imperative Care today announced positive efficacy and safety results from its pivotal SYMPHONY-PE thrombectomy system study.